Neutrophils and galectin-3 defend mice from lethal bacterial infection and humans from acute respiratory failure

Sudipta Das1, Tomasz W Kaminski2, Brent T Schlegel3

  • 1Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine and Acute Lung Injury Center of Excellence, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.

PubMed

Insights

Prior exposure to lipopolysaccharide (LPS) trains the innate immune system, enhancing neutrophil and macrophage defenses against lethal Pseudomonas aeruginosa infections. This LPS-mediated protection involves galectin-3, a key antibacterial protein, offering a novel therapeutic strategy.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa respiratory infections pose a life-threatening risk, particularly in hospitalized patients due to antibiotic resistance.
  • The potential for immune system education to combat P. aeruginosa remains an important research question.

Purpose of the Study:

  • To investigate whether prior exposure to lipopolysaccharide (LPS) can protect against lethal P. aeruginosa infection.
  • To elucidate the underlying innate immune mechanisms, focusing on neutrophils, macrophages, and galectin-3.

Main Methods:

  • Mice were exposed to a low dose of LPS prior to lethal P. aeruginosa challenge.
  • Immune cell populations, gene expression (phagocytosis, cell-killing), and galectin-3 levels were analyzed.
  • Intravital imaging, bacterial killing assays, and galectin-3-deficient mice were utilized.
  • Human patient data (endotracheal aspirates) from acute respiratory failure cases were analyzed for galectin-3 and immune cell signatures.

Main Results:

  • LPS pre-exposure conferred protection against lethal P. aeruginosa infection in mice.
  • LPS trained the innate immune system, expanding neutrophil and interstitial macrophage populations with enhanced phagocytic and cell-killing gene expression.
  • Neutrophils uniquely expressed Lgals3 (encoding galectin-3), a critical component of LPS-mediated protection.
  • Elevated galectin-3 levels in endotracheal aspirates correlated with survival and a favorable hypoinflammatory subphenotype in patients with acute respiratory failure.

Conclusions:

  • Prior LPS exposure effectively trains innate immunity, conferring protection against lethal P. aeruginosa infection.
  • Neutrophils and the antibacterial protein galectin-3 are central to this LPS-induced protective mechanism.
  • Galectin-3 levels in respiratory secretions may serve as a prognostic biomarker for patients with acute respiratory failure.